GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Gate AG (XTER:BIG1) » Definitions » Other Operating Expense

Bio-Gate AG (XTER:BIG1) Other Operating Expense : €5.47 Mil (TTM As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Bio-Gate AG Other Operating Expense?

Bio-Gate AG's Other Operating Expense for the six months ended in Dec. 2023 was €2.67 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was €5.47 Mil.

Bio-Gate AG's quarterly Other Operating Expense declined from Dec. 2022 (€2.93 Mil) to Jun. 2023 (€2.80 Mil) and declined from Jun. 2023 (€2.80 Mil) to Dec. 2023 (€2.67 Mil).

Bio-Gate AG's annual Other Operating Expense increased from Dec. 2021 (€4.36 Mil) to Dec. 2022 (€5.36 Mil) and increased from Dec. 2022 (€5.36 Mil) to Dec. 2023 (€5.47 Mil).


Bio-Gate AG Other Operating Expense Historical Data

The historical data trend for Bio-Gate AG's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Gate AG Other Operating Expense Chart

Bio-Gate AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.38 3.89 4.36 5.36 5.47

Bio-Gate AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.35 2.43 2.93 2.80 2.67

Bio-Gate AG Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €5.47 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bio-Gate AG Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Bio-Gate AG's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Gate AG (XTER:BIG1) Business Description

Traded in Other Exchanges
Address
Neumeyerstraße 28-34, Nürnberg, DEU
Bio-Gate AG is a Germany based medical technology company. The company employs silver technology to endow materials and products with antimicrobial properties. It is focused on the medical technology products portfolio. In addition, its technologies are also used to refine cosmetics, consumer goods, and industrial products. The products of the company are plasma-coating, additives, textile solutions, spray, masterbatches, and others. The organization uses two different technologies; first, silver particles are incorporated into cosmetics, paints, veneers or plastics, and second involve coating final products like implants or wound dressings with a silver-containing functional layer.
Executives
Karl Richter Supervisory Board

Bio-Gate AG (XTER:BIG1) Headlines

No Headlines